Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
**Sponsored Content**
Learn about an active clinical trial studying Y-90, an internal radiation treatment that aims to directly target brain cancer while minimizing harm to surrounding healthy tissue.
Discover how we’re closer to tripling our investment in research thanks to your support of Meet Hope Head On!
Sangami Pugazenthi is rewarded for her research exploring biological processes behind radiation resistance in grade 2 meningiomas.
Read our top takeaways from the Society for Neuro-Oncology (SNO) Annual Meeting, the world’s largest gathering of neuro-oncology experts.
**Sponsored Content**
Learn more about Biodexa’s Phase 1 clinical trial investigating the effectiveness of an approved blood cancer drug in liquid form to treat recurrent glioblastoma (GBM).
The American Brain Tumor Association (ABTA) today announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages. Dedicated to advancing the field of neuro-oncology and accelerating the discovery of life-saving treatments, the ABTA is proud to have invested more than $35 million, to approximately 700 researchers to support 800 projects, to date.
Join us in our mission to accelerate research breakthroughs and fuel hope for brain tumor patients and families.
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
Always free for patients & caregivers
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
